Top

Journal of Neurology

Published in:

01-08-2020 | Multiple Sclerosis | Original Communication

Longitudinal serum neurofilament light chain (sNfL) concentration relates to cognitive function in multiple sclerosis patients

Authors: Flavia Mattioli, F. Bellomi, C. Stampatori, S. Mariotto, S. Ferrari, S. Monaco, C. Mancinelli, R. Capra

Published in: Journal of Neurology | Issue 8/2020

Abstract

Background

Serum neurofilament light chain (sNfL) may be used as a biological marker of disease progression in multiple sclerosis (MS), although longitudinal studies correlating cognitive deficits to sNfL are limited.

Objective

To longitudinally investigate the relation between cognitive dysfunction, sNfL and MRI brain volume in a relapsing remitting MS patients.

Methods

18 MS patients (9 males and 9 females, mean age 45 years, mean education 12.6 years) all prescribed with interferon beta 1a (44 mcg 3 times per week), are longitudinally evaluated by means of annual clinical exam with EDSS, neuropsychological evaluation with Brief repeatable battery (BRB) and Delis Kaplan Executive function test (DKEFS), dosage of sNfL (SIMOA) and MRI.

Results

Here are reported the results of 1 year follow-up. A significantly higher sNfL in MS compared to healthy controls and higher sNfL in patients with greater cognitive impairment were found. Cognitive Impairment Index, memory, executive function tests correlated with sNfL. Gray matter volume resulted unchanged at 1-year follow-up; a weak correlation between some tests’ score and selective cortical brain areas was found.

Conclusion

Our longitudinal pilot study confirms that sNfL are related to cognitive abilities, confirming data of other authors from retrospective studies.

Benedict RH, Zivadinov R (2011) Risk factors for and management of cognitive dysfunction in multiple sclerosis. Nat Rev Neurol 7(6):332CrossRef

Chiaravalloti ND, DeLuca J (2008) Cognitive impairment in multiple sclerosis. Lancet Neurol 7(12):1139–1151CrossRef

Damasceno A, Pimentel-Silva LR, Damasceno BP, Cendes F (2019) Cognitive trajectories in relapsing–remitting multiple sclerosis: a longitudinal 6-year study. Mult Scler. https://doi.org/10.1177/1352458519878685 CrossRefPubMed

Ruano L, Portaccio E, Goretti B, Niccolai C, Severo M, Patti F, Cilia S, Gallo P, Grossi P, Ghezzi A, Roscio M (2017) Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes. Mult Scler J 23(9):1258–1267CrossRef

Portaccio E, Stromillo ML, Goretti B, Zipoli V, Siracusa G, Battaglini M, Giorgio A, Bartolozzi ML, Guidi L, Sorbi S, Federico A (2009) Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. Neurology 73(7):498–503CrossRef

Ruano L, Branco M, Portaccio E, Goretti B, Niccolai C, Patti F, Chisari C, Gallo P, Grossi P, Ghezzi A, Roscio M (2018) Patients with paediatric-onset multiple sclerosis are at higher risk of cognitive impairment in adulthood: an Italian collaborative study. Mult Scler J 24(9):1234–1242CrossRef

Meyer-Moock S, Feng YS, Dippel FW, Kohlmann T (2014) Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis. BMC Neurol 14:58. https://doi.org/10.1186/1471-2377-14-58 CrossRefPubMedPubMedCentral

Freedman MS (2016) Are we in need of NEDA? Mult Scler 22(1):5–6. https://doi.org/10.1177/1352458515617249 CrossRefPubMed

Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE, Alvarez-Cermeño JC, Andreasson U, Axelsson M, Bäckström DC, Bartos A, Bjerke M (2019) Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis. JAMA Neurol 76:1035CrossRef

10.

Teunissen CE, Iacobaeus E, Khademi M, Brundin L, Norgren N, Koel-Simmelink MJ, Schepens M, Bouwman F, Twaalfhoven HA, Blom HJ, Jakobs CA (2009) Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis. Neurology 72(15):1322–1329CrossRef

11.

Håkansson I, Tisell A, Cassel P, Blennow K, Zetterberg H, Lundberg P, Dahle C, Vrethem M, Ernerudh J (2017) Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing–remitting multiple sclerosis. Eur J Neurol 24(5):703–712CrossRef

12.

Martin SJ (2019) CSF neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case control studies. J Neurol Neurosurg Psychiatry 24:1059CrossRef

13.

Kuhle J, Disanto G, Lorscheider J, Stites T, Chen Y, Dahlke F, Francis G, Shrinivasan A, Radue EW, Giovannoni G, Kappos L (2015) Fingolimod and CSF neurofilament light chain levels in relapsing–remitting multiple sclerosis. Neurology 84(16):1639–1643CrossRef

14.

Hendricks R, Baker D, Brumm J, Davancaze T, Harp C, Herman A, Büdingen HC, Townsend M, Fischer SK (2019) Establishment of neurofilament light chain Simoa assay in cerebrospinal fluid and blood. Bioanalysis 11(15):1405–1418CrossRef

15.

Barro C, Benkert P, Disanto G, Tsagkas C, Amann M, Naegelin Y, Leppert D, Gobbi C, Granziera C, Yaldizli Ö, Michalak Z (2018) Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis. Brain 141(8):2382–2391CrossRef

16.

Jakimowski D, Zivadinov R, Ramantam N, Hagemejer J, Weinstock-Guttman B, Tomic D, Kropshofer H, Fuchs TA, Barro C, Leppert D, Yaldizli O, Khule J, Benedict RHB (2019) Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: a longitudinal retrospective 5-year study. Mult Scler J

17.

Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292–30217CrossRef

18.

Amato MP, Portaccio E, Goretti B, Zipoli V, Ricchiuti L, De Caro MF, Patti F, Vecchio R, Sorbi S, Trojano M (2006) The Rao’s Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population. Mult Scler J 12(6):787–793CrossRef

19.

Goretti B, Patti F, Cilia S, Mattioli F, Stampatori C, Scarpazza C, Portaccio E (2014) The Rao’s Brief Repeatable Battery version B: normative values with age, education and gender corrections in an Italian population. Neurol Sci 35(1):79–82CrossRef

20.

Mattioli F, Stampatori C, Bellomi F, Scarpazza C, Galli P, Guarneri C, Corso B, Montomoli C, Niccolai C, Goretti B, Amato MP (2014) Assessing executive function with the D-KEFS sorting test: normative data for a sample of the Italian adult population. Neurol Sci 35(12):1895–1902CrossRef

21.

Anderson AM, Easley KA, Kasher N, Franklin D, Heaton RK, Zetterberg H, Blennow K, Gisslen M, Letendre SL (2018) Neurofilament light chain in blood is negatively associated with neuropsychological performance in HIV-infected adults and declines with initiation of antiretroviral therapy. J Neurovirol 24(6):695–701CrossRef

22.

Quintana E, Coll C, Salavedra-Pont J et al (2018) Cognitive impairment in early stages of multiple sclerosis is associated with high cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain. Eur J Neurol 25(9):1189–1191CrossRef

23.

Disanto G, Barro C, Benkert P et al (2017) Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis. Ann Neurol 81:857–870CrossRef

24.

Magliozzi R, Cross AH (2020) Can CSF biomarkers predict future MS disease activity and severity? Mult Scler J. https://doi.org/10.1177/1352458519871818 CrossRef

Title: Longitudinal serum neurofilament light chain (sNfL) concentration relates to cognitive function in multiple sclerosis patients
Authors: Flavia Mattioli
F. Bellomi
C. Stampatori
S. Mariotto
S. Ferrari
S. Monaco
C. Mancinelli
R. Capra
Publication date: 01-08-2020
Publisher: Springer Berlin Heidelberg
Keyword: Multiple Sclerosis
Published in: Journal of Neurology / Issue 8/2020
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-020-09832-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Longitudinal serum neurofilament light chain (sNfL) concentration relates to cognitive function in multiple sclerosis patients

Abstract

Background

Objective

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Objective

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 8/2020

Metabolomic changes associated with frontotemporal lobar degeneration syndromes

Utriculo-ocular pathway dysfunction is more frequent in vestibular migraine than probable vestibular migraine

Contributions to the study of spinocerebellar ataxia type 38 (SCA38)

Wiktor Stein (1899–1979)

Etiologic distribution of dizziness and vertigo in a referral-based dizziness clinic in South Korea

Effects of perceptible and imperceptible galvanic vestibular stimulation on the postural control of patients with bilateral vestibulopathy